A. Richardson

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

T. Nielsen, E. Thompson, C. Sotiriou, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy.

E. Winer, R. Gelman, J. Garber, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TBCRC 030: A phase II study of preoperative cisplatin vs. paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker.

C. Perou, E. Winer, L. Trippa, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Prevalence of BRCA1 mutations in triple negative breast cancer (BC).

S. Schnitt, J. Garber, A. Richardson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers

Z. Szallasi, M. Dreze, A. Richardson, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparative effects of human-equivalent low, moderate, and high dose oral prednisone intake on autoimmunity and glucocorticoid-related toxicity in a murine model of environmental-triggered lupus

A. Richardson, Quanzhen Li, J. Buchweitz, 2022, Frontiers in Immunology.

TBCRC 003: Phase II trial of trastuzumab (T) and lapatinib (L) in patients (pts) with HER2+ metastatic breast cancer (MBC).

A. D. Van den Abbeele, E. Winer, R. Gelman, 2010, Journal of Clinical Oncology.

Personalizing treatment in early-stage breast cancer: The role of standard clinical factors and genomic information in adjuvant chemotherapy decision making.

E. Winer, H. Burstein, A. Richardson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.